Inactive Instrument
Argos Therapeutics Inc Share Price Nasdaq
Stocks
US0402211033
Pharmaceuticals
OTC Markets Traded| Market Cap | 318K 274K 257K 234K 441K 30.35M 443K 3.04M 1.19M 15.32M 1.19M 1.17M 50.81M | P/E 2016 |
-2.96x | P/E 2017 | -0.22x |
|---|---|---|---|---|---|
| Enterprise Value | 4.58M 3.95M 3.7M 3.38M 6.37M 438M 6.39M 43.95M 17.15M 221M 17.21M 16.84M 733M | EV / Sales 2016 |
200x | EV / Sales 2017 | 9.19x |
| Free-Float |
88.73% | Yield 2016 * |
-
| Yield 2017 | - |
| 1 day | +0.46% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.46% | +1,231.29% | - | - | 567K | |
| +0.15% | -4.17% | +37.39% | -3.93% | 79.3B | |
| -0.44% | +1.94% | -19.41% | -36.90% | 59.21B | |
| +2.68% | +1.74% | +484.13% | +24.97% | 55.09B | |
| +2.15% | -2.13% | -1.37% | +30.77% | 49.86B | |
| -0.88% | -2.41% | +7.78% | +159.30% | 47.9B | |
| -0.21% | -0.33% | +55.70% | -18.68% | 32.28B | |
| -1.19% | -4.16% | +42.65% | +90.07% | 25.21B | |
| -3.44% | +1.37% | +7.18% | +188.73% | 23.87B | |
| -3.28% | -0.13% | +59.51% | +113.33% | 16.89B | |
| Average | -0.40% | -1.05% | +74.84% | +60.85% | 43.29B | |
| Weighted average by Cap. | +0.06% | -1.88% | +84.29% | +41.40% |
| 2016 | 2017 | |
|---|---|---|
| Net sales | 945K 815K 764K 697K 1.31M 90.36M 1.32M 9.06M 3.54M 45.61M 3.55M 3.47M 151M | 1.9M 1.64M 1.53M 1.4M 2.64M 182M 2.65M 18.21M 7.1M 91.64M 7.13M 6.98M 304M |
| Net income | -53.03M -45.69M -42.84M -39.11M -73.68M -5.07B -73.91M -508M -198M -2.56B -199M -195M -8.48B | -40.58M -34.97M -32.78M -29.93M -56.38M -3.88B -56.56M -389M -152M -1.96B -152M -149M -6.49B |
| Net Debt | -13.11M -11.3M -10.59M -9.67M -18.21M -1.25B -18.27M -126M -49.03M -632M -49.22M -48.15M -2.1B | 4.27M 3.68M 3.45M 3.15M 5.93M 408M 5.95M 40.9M 15.96M 206M 16.02M 15.67M 683M |
Employees
-
Sector
Pharmaceuticals
